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Abstract
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Collagen hydrogels have been widely investigated as scaffolds for vascular tissue engineering due
in part to the capacity of collagen to promote robust cell adhesion and elongation. However,
collagen hydrogels display relatively low stiffness and strength, are thrombogenic, and are highly
susceptible to cell-mediated contraction. In the current work, we develop and characterize a
sequentially-formed interpenetrating network (IPN) that retains the benefits of collagen, but which
displays enhanced mechanical stiffness and strength, improved thromboresistance, high physical
stability and resistance to contraction. In this strategy, we first form a collagen hydrogel, infuse
this hydrogel with poly(ethylene glycol) diacrylate (PEGDA), and subsequently crosslink the
PEGDA by exposure to longwave UV light. These collagen-PEGDA IPNs allow for cell
encapsulation during the fabrication process with greater than 90% cell viability via inclusion of
cells within the collagen hydrogel precursor solution. Furthermore, the degree of cell spreading
within the IPNs can be tuned from rounded to fully elongated by varying the time delay between
the formation of the cell-laden collagen hydrogel and the formation of the PEGDA network. We
also demonstrate that these collagen-PEGDA IPNs are able to support the initial stages of smooth
muscle cell lineage progression by elongated human mesenchymal stems cells.

INTRODUCTION
Author Manuscript

Collagen hydrogels have been widely investigated as scaffolds for vascular tissue
engineering due in part to the abundance of collagen in the vessel wall and due to the
capacity of a range of cell types to elongate and spread within collagen networks [1–4] [5].
Yet, collagen networks also have critical shortcomings which limit their broader utility in
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vascular graft applications. For instance, L’Hereux et al. employed collagen hydrogels to
form the medial layer of their engineered vascular grafts [2]. However, the encapsulated
smooth muscle cells contracted the collagen gels by up to 70% within 4 days of culture.
Although adult mesenchymal stem cells (MSCs) are increasingly used as a source of smooth
muscle cells for tissue engineered vascular grafts [6–10], MSC-laden collagen hydrogels are
also prone to cell-mediated compaction [11]. In addition, Weinberg and Bell noted that
vascular grafts based on tubular collagen hydrogels were so highly distensible that they
ruptured at very low pressures (< 10 mmHg) and that increasing the concentration of
collagen had limited effect on hydrogel strength [4]. This restricted capacity to manipulate
collagen hydrogel strength is also reflected in the relatively limited range of stiffnesses
achievable with pure collagen hydrogels [12, 13]. Specifically, the elastic moduli of collagen
hydrogels range from 1–100 Pa [14, 15], significantly less stiff than that of small-diameter
vascular tissue (40–900 kPa) [16, 17]. Furthermore, collagen hydrogels have a tendency to
undergo rapid cell-mediated degradation, which can be challenging to control and predict,
and the thrombogenicity of collagen requires graft pre-endothelialization prior to
deployment [4, 18].

Author Manuscript

To reduce the thrombogenicity of collagen, researchers have linked thromboresistant
molecules, such as heparin and poly(ethylene glycol), to the collagen network with
promising results [19, 20]. Similarly, several strategies have been employed to enhance
collagen hydrogel stiffness, strength, and resistance to degradation and cell-mediated
compaction. For instance, Girton et al. demonstrated that glycation can be used to stiffen and
strengthen collagen networks [21]. Further studies have since demonstrated that glycation
reduces collagen susceptibility to matrix metalloproteinase degradation [22]. In addition,
glutaraldehyde, hexamethylene diisocyanate, cyanamide, and 1-ethyl-3-(3-dimethyl
aminopropyl) carbodiimide (EDC) have each been examined in terms of their capacity to
increase the mechanical properties and slow the degradation rate of collagen hydrogels [23].
However, these chemical treatments can also have unwanted side-effects. For instance,
glutaraldehyde-treated tissues are prone to calcification, a situation which is undesirable for
vascular graft applications [24].

Author Manuscript

To address the limitations of pure collagen hydrogels while avoiding the drawbacks of
chemical crosslinking treatments, we propose to combine collagen hydrogels with a
poly(ethylene glycol) diacrylate (PEGDA) hydrogel to form an interpenetrating network
(IPN). IPNs comprised of two distinct polymer networks have recently been shown to result
in increased hydrogel stability, stiffness, and strength relative to either single component
network [25–28]. Importantly, the component networks often contribute to IPN properties in
a synergistic, rather than simply an additive, manner [25, 26]. For instance, recent
polyacrylamide-alginate IPNs [27, 28] demonstrate an elastic modulus, tensile strength, and
strain at failure that exceed the sum of the corresponding properties of the individual
networks.
In the present work, we combine a covalently-crosslinked PEGDA network with a
physically-crosslinked collagen network. PEGDA was selected as the second component of
this collagen-based IPN due to the established biocompatibility, low thrombogenicity, and
resistance to cell-mediated compaction characteristic of PEGDA hydrogels [29–31]. In
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addition, the degradation rate and mechanical properties of PEGDA hydrogels can be
systematically tailored. Specifically, although pure PEGDA hydrogels degrade relatively
slowly, their degradation rate can be modified by introduction of hydrolytically or
enzymatically-degradable segments within the PEG network [32–36]. Similarly, the
mechanical performance of PEGDA hydrogels can be tuned by varying the molecular weight
(MW) and concentration of PEGDA in the hydrogel precursor solution [37, 38]. Given these
properties, it is reasonable to assume that a collagen-based IPN which includes PEGDA as
the second network may display improved thromboresistance, higher resistance to cellmediated compaction, and an increased range of mechanical properties relative to pure
collagen.

Author Manuscript
Author Manuscript

Most IPNs, including those previously formed from PEG and collagen [39], are fabricated
by mixing the two component polymers followed by their simultaneous crosslinking into
interwoven networks [25, 27, 28, 39]. Unfortunately, in the case of collagen-PEG IPNs, this
fabrication approach forces cells encapsulated within the IPN to take on a rounded cell
phenotype, despite the presence of collagen. This is due to the nanoscale mesh structure and
slow degradation rate of pure PEGDA hydrogels [40]. We propose to circumvent this
limitation by first forming the collagen hydrogel and then infusing this hydrogel with
PEGDA. Subsequent exposure of the infused network to longwave UV light will result in the
formation of a PEGDA network interlaced with the pre-formed collagen network. As shown
schematically in Figure 1, the degree of cell spreading in the IPN network can be controlled
by varying the time delay between collagen hydrogel formation and PEGDA infusion and
polymerization. In the current work, we demonstrate that this hybrid natural-synthetic IPN
retains the benefits of collagen in terms of enabling robust cell elongation while improving
scaffold stiffness and strength as well as scaffold resistance to compaction and platelet
adhesion. Furthermore, we show the ability of these collagen-PEGDA IPNs to support the
initial stages of MSC progression toward a smooth muscle cell lineage.

MATERIALS AND METHODS
Polymer Synthesis and Characterization

Author Manuscript

PEGDA was prepared as previously described [41] by combining 0.1 mmol/ml dry PEG
(3.4, 6.0, or 10.0 kDa; Fluka), 0.4 mmol/ml acryloyl chloride, and 0.2 mmol/ml
triethylamine in anhydrous dichloromethane and stirring under argon overnight. The
resulting solution was washed with 2 M K2CO3 and separated into aqueous and
dichloromethane phases to remove HCl. The organic phase was subsequently dried with
anhydrous MgSO4, and PEGDA was precipitated in diethyl ether, filtered, and dried under
vacuum. Acrylation of the PEG end hydroxyl groups was characterized by 1H-NMR to be ≈
95%.
IPN Fabrication Process
Collagen-PEGDA IPNs were fabricated under sterile conditions via a three-step process
outlined schematically in Figure 1: 1) the physical crosslinking of a pure collagen network,
2) followed by the infiltration of the collagen hydrogel with a 3.4 kDa, 6.0 kDa or 10.0 kDa
PEGDA solution, and 3) UV polymerization of the infiltrating PEGDA solution. In brief,
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ice-cold high-concentration rat tail collagen I (BD Biosciences) was diluted and neutralized
with 1 M NaOH, 10X PBS and dIH2O to achieve the desired final collagen concentration
(1.5 mg/mL, 3 mg/ml, or 5 mg/mL) in 1X PBS. Three hundred microliters of the neutralized
ice-cold solution was then pipetted into BD Falcon culture inserts (12 mm diameter, 0.8 μm
pore size) followed by polymerization via 30 min incubation at 37 °C and 5% CO2. The
resulting hydrogels were then immersed for 30 min in serum-free medium (SFM) composed
of phenol-red free, high glucose DMEM (Gibco, Life Technologies) supplemented with 1%
sodium pyruvate (Gibco, Life Technologies) and 1% Glutamax (Gibco, Life Technologies).

Author Manuscript

The second polymer network was created as follows: the SFM solution surrounding the
previously cured collagen constructs was carefully removed and replaced with 1.7 ml of
sterile-filtered SFM containing 11.7% w/v PEGDA and 0.26% w/v photoinitiator (Irgacure
2959). The concentration of PEGDA in this precursor solution was selected to achieve a
nominal PEGDA concentration of approximately 10% w/v PEGDA within the collagen
hydrogel. This PEGDA solution was then allowed to infiltrate the collagen network for 15–
60 min at 37 °C. Excess PEGDA solution was then removed, and the PEGDA within the
collagen hydrogel was polymerized by 6 min exposure to longwave UV light (Spectroline, ≈
6 mW/cm2, 365 nm). The resulting IPNs were immersed in culture media (CM; SFM
supplemented with 10% MSC qualified FBS) until further analysis.

Author Manuscript

Tailoring Infiltration Time—The fabrication of stable and homogeneous IPNs by the
above methodology requires that the infiltration time of the PEGDA solution be
appropriately selected. To determine the penetration time necessary for the infiltrating
PEGDA solution to reach its equilibrium concentration within the collagen hydrogel, an
11.7% w/v solution of an intermediate molecular weight PEGDA (6.0 kDa) was allowed to
diffuse into a 3.0 mg/mL collagen hydrogel for 15 min, 30 min, 45 min or 60 min at 37 °C
prior to UV polymerization. The resulting IPNs were immersed in CM for 24 h, after which
they were exposed to the mechanical and swelling assessments described below. Pure
collagen (3 mg/mL) and pure PEGDA (6 kDa, 10% w/v) hydrogel controls were also
evaluated by the same methods.

Author Manuscript

Rheological Testing: Three to six hydrogel discs (8 mm diameter) per PEGDA infiltration
time were used to characterize the rheological behavior of each resulting IPN. Hydrogels
were blotted gently to remove excess water and placed on the testing stage of an Anton-Paar
Physica MCR 301 rheometer fitted with an 8 mm diameter upper platen. The gap distance
between the upper and lower platen was adjusted to achieve a 100 μm indentation depth
within each IPN. Dynamic oscillatory frequency sweeps were then conducted at room
temperature between 0.1 Hz and 100 Hz, with 10 measurement points per decade at a
constant shear stress of 2%. Shear storage modulus (G′) and shear loss modulus (G″) were
each evaluated as a function of frequency.
Tensile Ring Testing: The effect of infiltration time on IPN mechanical properties was also
evaluated using a modification of the circumferential property testing technique previously
validated for arterial ring specimens [42]. In brief, three to five 8 mm discs were further
separated into a 6 mm inner disc and an outer 8 mm ring using a 6 mm sterile biopsy punch.
Each outer 8 mm ring was mounted onto an Instron 3342 by threading opposing stainless
Biomaterials. Author manuscript; available in PMC 2017 June 13.
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steel hooks through the segment lumen. The hooks were then uniaxially separated at a rate
of 6 mm/min until construct failure. As hook separation increased, the mounted ring was
drawn into an increasingly oblong conformation. Johnson et al. confirmed that the force
applied by the hooks to this oblong oval could be approximated as being equally distributed
between two rectangles, each with sides equal to the width and wall thickness, hv, of the
ring. The gauge length, lg, was taken to be the inner diameter, Dv, of the unstretched ring
plus hv, and the elastic modulus, E, of each sample was defined as the slope of the resulting
linear stress–strain curve.

Author Manuscript

Swelling: Swelling measurements were performed as an additional indicator of the degree of
PEGDA infiltration within the collagen networks. Twenty-four hours following IPN
fabrication, three to six swollen constructs per IPN type were transferred to sterile PBS for 4
h at room temperature, after which the swollen weight (Ws) of each sample was recorded.
The dry weight (Wd) of each specimen was subsequently recorded after 24 h of
lyophilization. The equilibrium mass swelling ratio (q) was then calculated for each
collagen-PEGDA IPN formulation as

.

Based on the resulting rheological and swelling data, it was determined that 45 min was
sufficient for equilibrium PEGDA infiltration to be achieved in the collagen networks
employed (Figure 2). However, to ensure equilibrium PEGDA infiltration, all further
collagen-PEGDA IPNs were prepared using a 60 min infiltration time.
Tailoring the Mechanical Properties of Collagen-PEGDA IPNs

Author Manuscript

Varying the Molecular Weight of PEGDA: In pure PEGDA hydrogels, scaffold
mechanical properties can be modulated by varying PEGDA molecular weight (MW) and/or
concentration [37, 38, 43]. In this study, we chose to focus on the effects of PEGDA MW in
modulating IPN mechanical properties. We did not vary PEGDA concentration, as
increasing PEGDA concentration would have extended the time needed for the infiltrating
PEGDA solution to achieve equilibrium within the collagen hydrogel. In examining the
effects of PEGDA MW, the concentration of collagen within the collagen hydrogel was
maintained at 3 mg/mL and the PEGDA MW in the infiltration solution was varied (3.4 kDa,
6.0 kDa, or 10.0 kDa PEGDA) with a 60 min infiltration time. The resulting IPNs and
corresponding pure PEGDA and collagen hydrogel controls were immersed in CM for 24 h,
followed by ring tensile testing as described above.

Author Manuscript

Varying the Concentration of Collagen: By varying the concentration of collagen in the
hydrogel precursor solution, the stiffness of collagen hydrogels can be tuned. We therefore
also examined the potential impact of variations in collagen concentration on overall IPN
tensile properties. In brief, collagen hydrogels were prepared at 1.5 mg/mL, 3 mg/mL, and 5
mg/mL. An 11.7% w/v solution of the intermediate molecular weight PEGDA (6.0 kDa) was
allowed to infiltrate the collagen gels for 60 min, followed by UV polymerization. After 24 h
immersion in CM, mechanical testing was performed according to the rheological testing
method described above.
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For microstructural assessment, 8 mm diameter collagen-PEGDA IPN discs were fabricated
as described above using 3 mg/mL of collagen and 6.0 kDa PEGDA. Following 24 h
immersion in CM, the IPN discs were processed for confocal microscopy or scanning
electron microscopy (SEM), as outlined below.

Author Manuscript

Confocal Microscopy Imaging—The collagen-PEGDA IPN discs were fixed in
formalin for 1 h, and 1 mm thick transverse sections were cut from each disc using a razor
blade. Each section was washed with PBS and blocked with 3% bovine serum albumin
(BSA) in PBS for 1 h. Samples were then exposed to primary antibody for collagen I
(Rockland Immunochemicals) diluted in staining buffer (PBS containing 3% BSA and
0.05% Tween 20) for 12 h at 4 °C. Sections were subsequently rinsed 3 times with PBS, and
donkey anti-rabbit Alexa Fluor 488 secondary antibody (Life Technologies) diluted in
staining buffer was applied for 12 h at 4 °C. Following rinsing in PBS to remove unbound
secondary antibody, confocal microscopy was performed using a Zeiss LSM 510 META
confocal microscope equipped with a 40X water immersion objective. Four randomly
selected regions in each sample segment were imaged.

Author Manuscript

Scanning Electron Microscopy Imaging—SEM was performed on collagen-PEGDA
IPN hydrogels using a FEI Quanta 600F SEM with secondary electron detector. The
hydrogels were prepared for electron microscopy by transverse sectioning, followed by
fixation and serial dehydration with ethanol and hexamethyldisilazane according to the
method described by Raub et al. [44]. Prior to imaging, dried hydrogels were mounted on
SEM sample stages using carbon tape and sputter coated with Pd/Pt to a thickness of 6 nm
using a Cressington 208HR sputter coater. Each specimen was then imaged at 5 kV using
magnifications of 1500X and 40000X.
Cell Studies

Author Manuscript

Cryopreserved human mesenchymal stem cells (MSCs; Lonza) at passage 2 were thawed
and expanded in monolayer culture. Prior to encapsulation, cells were maintained at 37 °C
and 5% CO2 in MesenPRO RS medium (Gibco, Life Technologies). For each of the cell
studies below, MSCs were harvested at passage 4 and encapsulated at 7.5×105 cells/ml as
described above. Collagen-PEGDA IPNs containing 3 mg/mL collagen and 6.0 kDa PEGDA
were selected for evaluation due to the prior use of 10 % w/v 6.0 kDa PEGDA hydrogels in
vascular tissue engineering studies [45, 46]. Cells were allowed to spread in the collagen
network for 0 h, 4 h or 6 h in either SFM or CM prior to infiltration with an 11.7% w/v 6.0
kDa PEGDA solution for 60 min, followed by 6 min exposure to longwave UV light. The
resulting cell-laden IPNs were incubated at 37 °C and 5% CO2 and cultured in CM for up to
14 days with media changes every 2 days.
Cell Viability Assessments—Twenty-four hours post-fabrication, cell-laden IPNs were
exposed to Live/Dead Cell Viability Assay reagents (Life Technologies) per the
manufacturer’s protocol. One mm thick transverse sections were cut from each hydrogel
disc using a razor blade. Fluorescence images of the Live/Dead stained cells were obtained
from 10 randomly selected regions of each transverse section using confocal microscopy.
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Images were processed using ImageJ software to compute the number of viable versus dead
cells.
Evaluation of the Ability of the IPN to Support Cell Elongation—To quantitatively
assess cell elongation as a function of the time delay between collagen I network formation
and PEGDA infiltration, cell-laden IPNs formed with delay times of 0, 4, and 6 h were fixed
in formalin for 30 min, followed by exposure to 66 nM rhodamine phalloidin (Life
Technologies) and 300 nM DAPI dilactate (Life Technologies) for 1 h at room temperature.
Discs were then rinsed to remove unbound phalloidin and DAPI. One mm thick transverse
sections were cut from each hydrogel disc using a razor blade. Cell shape information was
then obtained from confocal microscopy images of the actin networks of the encapsulated
cells from 4 randomly selected regions of each transverse section. Circularity (C) and
roundness (R) measurements were obtained using ImageJ software. In brief,

and
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were calculated for each cell, where A and P are the cell area and perimeter,
respectively, and where a is the length of the major axis of the cell [47].
Assessment of Cell-Mediated IPN Compaction—Collagen-PEGDA IPNs were
prepared with a 6 h time delay between collagen hydrogel formation and PEGDA infiltration
to ensure MSC elongation. These IPNs were cultured for 14 days alongside pure PEGDA
and pure collagen I hydrogel controls prepared with similar initial cell densities (7.5×105
cells/mL). Compaction was assessed by monitoring changes in hydrogel dimensions using a
digital micrometer over the course of 14 days of culture.

Author Manuscript

Capacity of the IPN to Support Initial Smooth Muscle Cell Lineage
Progression—Collagen-PEGDA IPNs were prepared with a 6 h time delay between
collagen hydrogel formation and PEGDA infiltration to ensure MSC elongation. The
resulting IPNs were initially immersed in DMEM containing 10% MSC-qualified FBS and
1% penicillin/streptomycin/amphotericin solution. After 24 h of culture, a set of gels was
harvested as “day 0” specimens, snap-frozen, and stored at −80 °C until analysis. Remaining
gels were then cultured in DMEM supplemented with 10% MSC-qualified FBS, and 10
ng/mL TGF-β3, with media changes every two days. After 14 days of culture, these IPNs
were harvested and snap-frozen for subsequent analysis.

Author Manuscript

MSC phenotypic progression within the day 14 IPNs was evaluated by qRT-PCR relative to
day zero. Specifically, gene expression for smooth muscle alpha actin (SM-α-actin), smooth
muscle 22 alpha (SM22α) and calponin h1 (CNN1) was quantified relative to the
housekeeping gene GAPDH. Since TGF-β3 can also induce chondrogenesis in MSC cultures
[48], the chondrogenic markers sox9 and collagen II were also evaluated to assess the
presence of this undesired lineage. In brief, mRNA was extracted using the Dynabeads
mRNA direct kit (Ambion, Life Technologies). In brief, a 6 mm disc was cored from each of
the IPN constructs and transferred to a 1.7 ml RNase-free conical tube containing 330 μL of
the provided lysis binding buffer. The samples were then homogenized using a plastic
RNase-free pestle (Kimble Chase) and incubated at room temperature for 10 min. Following
incubation, the samples were centrifuged for 5 min at 10,000 rpm and the polyA-mRNA in
the supernatant was harvested using 20 μL of Dynabeads oligo (dT)25 magnetic beads.
Biomaterials. Author manuscript; available in PMC 2017 June 13.
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Following rinsing steps, the polyA-mRNA was released from the Dynabeads in 100 μL of 10
mM Tris-HCl by heating the beads to 80 °C for 2 min.
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Proprietary qRT-PCR verified primers for human SM-α-actin, SM22α, CNN1, sox9,
collagen II and GAPDH were purchased from Origene. qRT-PCR was performed on each
sample using a StepOne real-time PCR system (Life Technologies) and the SuperScript III
Platinum One-Step qRT-PCR kit (Invitrogen, Life Technologies). mRNA levels for each
gene of interest were assessed in duplicate for each construct. Approximately 3 ng of polyAmRNA and 5 μL of 1 mM primer were added per 25 μL of reaction mixture. Amplification
during the PCR phase was monitored by measuring the change in SYBR Green
fluorescence, with ROX dye serving as a passive reference. A threshold fluorescence value
at which each sample was in the exponential phase of amplification was identified using
StepOne software v2.0. The amplification cycle at which a given sample exceeded this
threshold was recorded as the Ct for that sample. For each sample, expression of each gene
of interest was calculated relative to GAPDH using the ΔΔCt method. Melting temperature
analysis was performed for each PCR reaction to verify the appropriate amplification
product.
Platelet Adhesion Assessment

Author Manuscript

The thrombogenicity of the collagen-PEGDA IPNs was evaluated relative to pure collagen
hydrogels using platelet adhesion studies per standard protocols [49]. IPNs were fabricated
using 3 mg/mL of collagen and 11.7 % w/v 6.0 kDa PEGDA via the sequential process
described above. The resulting IPNs and corresponding collagen hydrogel controls were
immersed in CM for 24 h, followed by exposure of four hydrogels from each group to 1 mL
of porcine whole blood containing heparin (Lampire, Biological Laboratories). After 2 h of
incubation, the blood was gently removed from each surface, and hydrogels were rinsed five
times for 5 min at room temperature with 1 mL of Dulbecco’s PBS (Gibco, Live
Technologies). Adherent platelets were then lysed for 20 min at room temperature using 1
ml of lysis solution from the LDH Cytotoxicity Detection Kit (Roche). The total number of
adhered cells was indirectly quantified by the measurement of lactate dehydrogenase (LDH)
levels in the lysate [49].
Statistical Analyses
Data are reported as mean ± standard deviation. Comparison of sample means was
performed using ANOVA followed by Tukey’s post-hoc test (SPSS software), p < 0.05.

RESULTS
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Tailoring the IPN Fabrication Process
In terms of fabricating the collagen-PEGDA IPNs, it was important to first identify the
infiltration time needed for the infusing PEGDA precursor solution to reach its equilibrium
concentration throughout the pre-formed collagen hydrogel [50]. Thus, a series of
experiments were conducted in which the PEGDA infiltration solution was allowed to
diffuse into a 3 mg/mL collagen hydrogel for 15 min, 30 min, 45 min or 60 min prior to UVinitiated PEGDA polymerization. The resulting IPNs were immersed in culture media for 24
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h, after which they were characterized in terms of shear storage modulus (G′), shear loss
modulus (G″), and mass swelling ratio (q). Results from these assays are shown in Figure
2A–C. As expected, both the G′ and G″ of the collagen-PEGDA IPNs increased with
increasing infiltration time up through 45 min. Beyond this infiltration time, no further
statistically significant changes in G′ or G″ were observed, indicating that equilibrium
infusion of the PEGDA solution was achieved at 45 min infiltration time. Tensile ring testing
supported these rheological results. Specifically, IPN tensile modulus increased from ≈ 37
kPa at a 15 min infiltration time to ≈ 78 kPa at a 45 min infiltration time (Table 1). Similarly,
no further significant changes in IPN tensile modulus were observed between 45 min and 60
min infiltration time. These trends were also observed for tensile strength (Table 1).

Author Manuscript
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As with mechanical property testing, mass swelling assessments can give quantitative insight
into the extent of PEGDA diffusion into the collagen hydrogel prior to PEGDA crosslinking.
The equilibrium mass swelling ratios of the collagen-PEGDA IPNs decreased with
increasing infiltration time through 45 min (p < 0.010), after which no further significant
reductions were observed (Figure 2C). Furthermore, the post-swelling concentration of
PEGDA in IPNs as a function of infusion time was calculated from the obtained swelling
data. The concentration of PEGDA in the IPN after 15 min of infiltration time reached 6.1
± 0.1% w/v and monotonically increased until attaining equilibrium at 45 min infusion time.
The equilibrium infusion time was set as the time beyond which the post-swelling PEGDA
concentration in the IPN was statistically indistinguishable from that of the PEGDA control
formulation (7.0% w/v post-swelling, 10% w/v nominal). Detailed data information of the
post-swelling concentration of PEGDA in each IPN formulation as a function of infusion
time has been reported in the Supplementary Table 1. As such, both the mechanical testing
and swelling data indicate that a 45 min infiltration time was sufficient for an 11.7 % w/v
solution of 6.0 kDa PEGDA to reach equilibrium levels within a 3 mg/mL collagen
hydrogel. However, to ensure that equilibrium PEGDA infiltration was achieved in our
studies, all further collagen-PEGDA IPNs were prepared using a 60 min infiltration time.
Mechanical Testing Assessment at Equilibrium PEGDA Infiltration
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In further examining the mechanical data in Figure 2, the shear storage modulus (G′) and
shear loss modulus (G″) were each substantially greater for the equilibrium IPN (45–60 min
infiltration time) than for the single network PEGDA and collagen hydrogel controls.
Specifically, the G′ for the IPN at 60 min infiltration time was 136-fold greater than the
pure collagen control and 3-fold greater than the PEGDA control (p < 0.001). Similarly, a
140-fold increase in G″ was observed for the equilibrium IPN relative to the pure collagen
hydrogel control (p < 0.001) and a 1.6-fold increase was observed relative to the PEGDA
control (p < 0.001).
This increase in IPN storage and loss modulus relative to the individual component networks
was also reflected in the tensile modulus data. Specifically, the tensile modulus of the
collagen-PEGDA IPN at equilibrium PEGDA infiltration was approximately 2.5-fold greater
than that of the pure PEGDA control (p = 0.001, Table 1). Similarly, the tensile strength (TS)
of the IPN at 60 min infiltration time was ≈ 2.4-fold greater than the TS of the PEGDA
control (p = 0.002), with a TS of approximately 100 kPa being achieved for the collagen-
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PEGDA IPN (Table 1). This value of TS is over an order of magnitude larger than that of the
tubular collagen hydrogels previously utilized in vascular graft construction [5].
To gain insight into the elasticity of the collagen-PEGDA IPN, the rheological data was used
to determine the loss tangent (G″/G′) of the IPN compared to that of the pure PEGDA
control. The loss tangent for the collagen-PEGDA IPN was 0.11 ± 0.01, significantly lower
than the 0.19 ± 0.06 loss tangent of pure PEGDA hydrogels (p = 0.040). This indicates that
the IPNs may have increased elasticity relative to pure PEGDA gels, which are generally
considered to be highly elastic.
Post-Encapsulation Cell Viability
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Prolonged exposure of cells to high concentrations of solubilized, uncrosslinked PEGDA
can have cytotoxic effects. As such, it was important to assess the viability of cells through
the sequential encapsulation process associated with IPN formation. Toward this end, human
MSCs were encapsulated within a 3 mg/mL collagen hydrogel followed by either a 0 h or a
6 h delay time. The gels were then exposed to an 11.7 % w/v solution of 6.0 kDa PEGDA
for 60 min prior to UV polymerization. Live/Dead staining performed 24 h following
encapsulation indicated cell viability levels of 91.1 ± 1.2% in IPNs fabricated with 0 h
delay-time between collagen network formation and the onset of PEGDA infiltration. IPNs
formed with a 6 h delay-time were associated with a cell viability of 95.1 ± 1.6%.
Representative Live/Dead images can be seen in Supplementary Figure 1. These viability
results are consistent with data from Nuttelman et al., which showed human MSC viability
in photocrosslinked PEGDA hydrogels to fall between 75% and 97% [51]. In addition, the
present MSC viability results suggest that the IPN fabrication strategy used in this study
provides similar cytocompatibility compared to other IPN cell encapsulation strategies,
where viability ranges from 47 % to 96 % [52, 53]. Thus, a 60 min exposure to solubilized
PEGDA prior to crosslinking appears to be cytocompatible at the concentration of PEGDA
employed.
Tailoring the Mechanical Properties of Collagen-PEGDA IPNs
In pure PEGDA hydrogels, scaffold mechanical properties can be modulated by varying
PEGDA molecular weight (MW) and concentration [37, 38, 54, 55]. Collagen hydrogel
mechanical properties can also be tuned by tailoring the concentration of collagen [14]. To
demonstrate the tunability of this IPN system, we have therefore examined the effects of
PEGDA MW and collagen concentration on IPN mechanical properties.

Author Manuscript

Effect of PEGDA MW—In assessing the effects of PEGDA MW, 3.4 kDa, 6 kDa, and 10
kDa PEGDA was utilized. Consistent with PEGDA hydrogel literature, a decrease in
PEGDA MW led to a significant increase in tensile modulus for the pure PEGDA controls (p
= 0.008; Figure 3A). This modulation of stiffness by PEGDA MW was also reflected in the
collagen-PEGDA IPN series, with the average tensile modulus of the IPNs increasing from
25.2 ± 1.4 kPa for 10.0 kDa PEGDA to 103.2 ± 20.3 kPa for 3.4 kDa PEGDA (p ≤ 0.001).
Rheological assessments indicated a similar increase in IPN shear elastic modulus with
decreasing PEGDA MW (p < 0.028), with G′ for the IPN containing 3.4 kDa PEGDA being
≈ 2.2-fold greater than for the IPN containing 10 kDa PEGDA (Table 2). TS of the collagen-
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PEGDA IPNs also increased from ≈ 47 kPa to over 100 kPa as PEGDA MW decreased from
10 kDa to 3.4 kDa (p = 0.002, Figure 3B).
These PEGDA MW data also reveal consistent trends with the equilibrium IPN results
containing 6.0 kDa PEGDA discussed in the previous section. Specifically, the average
tensile modulus (p ≤ 0.001) and average TS (p ≤ 0.002) of the IPNs containing 3.4 kDa, 6.0
kDa, or 10 kDa PEGDA was increased 1.6–2.5-fold relative to the corresponding pure
PEGDA controls. Furthermore, the elasticity of the IPNs was greater than their
corresponding pure PEGDA counterparts per loss tangent calculations for each PEGDA MW
examined (Table 2). Importantly, several of the examined IPN tensile modulus values fall
within the range of health vascular tissue (40 – 900 kPa) [16, 17].
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Effect of Collagen Concentration—To assess the effect of collagen concentration on
IPN mechanical properties, 3 collagen hydrogel types were prepared: 1.5 mg/mL, 3 mg/mL,
and 5 mg/mL. These hydrogels were then exposed to an 11.7 % w/v solution of 6.0 kDa
PEGDA for 60 min, followed by PEGDA polymerization. The average rheological
properties of the resulting IPNs are given in Table 3. As anticipated, G′ increased with
increasing collagen concentration, from 11.0 ± 4.6 kPa at 1.5 mg/mL collagen to 21.7 ± 4.1
kPa at 5.0 mg/mL collagen (p = 0.003). Furthermore, the loss tangent decreased by a factor
of 2 from 1.5 mg/mL collagen to 5 mg/mL collagen, indicating that IPN elasticity increased
with increasing collagen concentration (p = 0.001). These results are consistent with the
increased G′ and increased elasticity reported for pure collagen gels over a similar collagen
concentration range [56]. Cumulatively, the above PEGDA MW and collagen concentration
data demonstrate the mechanical tunability of the collagen-PEGDA IPNs.
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IPN Microarchitectural Characterization
To further characterize the developed IPNs, their microarchitecture was examined using
standard microscopy techniques To visualize the native state and distribution of the fibrillar
collagen network within the swollen hydrogels, immunostaining for collagen I was
performed followed by confocal microscopy. Representative confocal images of a 3 mg/mL
collagen hydrogel, 6.0 kDa PEGDA 10% w/v hydrogel and the 60 min infiltrated IPN with
6.0 kDa PEGDA are shown in Figure 4. The fibrillar collagen network within the pure
collagen and the IPN is apparent, and the collagen fibrils appear to be relatively evenly
distributed within the matrix. In contrast, no fibers were observed in the pure PEGDA
control formulation, which has no intrinsic fluorescence.
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To visualize both the PEGDA and collagen components of the IPN, SEM imaging was
employed. Figure 5A shows representative SEM images of a pure PEGDA hydrogel,
whereas Figure 5B displays representative images of a collagen-PEGDA IPN. In the IPN
images, collagen fibrils entangled with flat PEGDA structures can be seen. The average
thickness of these collagen fibrils was measured as approximately 60 nm using the SEM
software measurement tool. This diameter value is consistent with that observed in other
studies for collagen hydrogels cured at neutral pH and temperature of 37 °C [44].

Biomaterials. Author manuscript; available in PMC 2017 June 13.

Munoz-Pinto et al.

Page 12

IPN Ability to Support an Elongated Cell Phenotype

Author Manuscript

Pure PEGDA hydrogels are not permissive to cell elongation following PEGDA
polymerization, even in the presence of incorporated cell adhesion ligands. This is due to the
tight, nanoscale mesh structure and resistance to degradation that is characteristic of PEGDA
gels [57]. To enable cell elongation within this IPN system, we therefore chose to rely on the
capacity of collagen hydrogels to facilitate cell spreading. In brief, MSCs were encapsulated
within 3 mg/mL collagen hydrogels, and then incubated in the presence of serum-free
culture medium for 0, 4, or 6 h prior to exposure to PEGDA (also dissolved in serum free
medium) for 60 min. Following PEGDA polymerization, each disc was immersed in
medium containing 10% serum and cultured for 24 h prior to imaging.
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The average extent of cell elongation was assessed by quantification of cell circularity (C)
and roundness (R). The measures serve as quantitative measures of cell shape, where values
of C and R significantly less than 1 correspond to a high degree of cell elongation and values
of C and R closer to 1 correspond to more rounded morphology. As expected, both cell
circularity and roundness decreased as the time for cell spreading in the collagen network
prior to PEGDA infusion increased from 0 h to 6 h. Specifically, circularity decreased from
0.5 to 0.28 as the delay-time between collagen network formation and PEGDA infiltration
increased from 0 h to 6 h (p < 0.001, Figure 6A). Similarly, roundness was reduced from
0.64 to 0.38 with increasing delay-time (p < 0.001, Figure 6B). These quantitative changes
in cell morphology corresponded to a shift from rounded cells at 0 h to spindle-shaped cells
at 6 h, as shown in Figure 7. These cell shapes were maintained through 2 weeks of culture
(Supplementary Figure 2).
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Cumulatively, the present data demonstrate that the sequentially polymerized collagenPEGDA hydrogel system retains the benefits of collagen hydrogels in terms of enabling cell
elongation.
IPN Resistance to Cell-Mediated Compaction
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To assess the resistance of the collagen-PEGDA IPNs to cell-mediated compaction, IPNs
fabricated with a 6 h delay time, i.e. containing elongated MSCs, were cultured for 14 days.
Compaction was assessed by monitoring changes in hydrogel dimensions over the course of
14 days of culture. No alteration in IPN thickness was observed through the culture period
(Figure 8A). Similarly, the lateral dimensions of the IPN networks were also maintained
over 14 days of culture (Figure 8B and the Supplementary Table 2). These results are
consistent with the resistance to cell-mediated compaction characteristic of pure PEGDA
hydrogels. In contrast, the diameter of pure collagen hydrogels at 14 days of culture was
reduced 60.3 ± 8.2 % relative to day 0 (Figure 8B).
Collagen hydrogels enable significant cell proliferation, whereas PEGDA-containing
hydrogels do not, due in part to their nanoscale crosslinks and slow degradation rates [37,
38]. Thus, the above studies do not enable matrix compaction resulting from a potential
increase in cell number to be distinguished from intrinsic hydrogel susceptibility to
compaction. An additional set of hydrogels were therefore prepared containing h-MSCs pretreated with 8 μg/mL mitomycin C (MMC), a potent inhibitor of cell proliferation. MMC
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pre-treated hydrogels could be considered to have a relatively constant total cell number over
the 14 day culture period. In the MMC-treated set, differences in the extent of collagen
hydrogel and IPN compaction could therefore be attributed to differences in their intrinsic
susceptibility to cell-mediated compaction. Significant reduction in the diameter (~37.9
± 3.2 %) of the MMC-treated collagen hydrogels was observed, although no change was
observed for the IPNs (Figure 8B). Therefore, the collagen-PEGDA IPNs displayed an
increased resistance to cell-mediated matrix compaction relative to pure collagen.
IPN Capacity to Support Smooth Muscle Cell Lineage Progression

Author Manuscript

Adult mesenchymal stem cells (MSCs) are increasingly used as a source of smooth muscle
cells for tissue engineered vascular grafts [6–10]. We therefore evaluated the capacity of the
collagen-PEGDA IPNs to support MSC differentiation to vascular smooth muscle cells in
the presence of TGF-β3, a growth factor which can support either smooth muscle cell or
chondrogenic differentiation depending on microenvironmental factors [58].
Following 14 days of culture, elongated MSCs encapsulated within an IPN containing 3
mg/mL collagen and 10 % w/v of 6.0 kDa PEGDA exhibited a 13.7-, 9.8-, and 9.5-fold
increase in the gene expression of smooth muscle cells markers SMα-actin, SM22α and
CNN1, respectively, relative to day zero (p < 0.004, Figure 9). On the other hand, no
alteration in gene expression of the chondrogenic transcription factor sox9 was observed
between day 14 and day 0 of culture, and mRNA for collagen II was not detected. These
data indicate that the 6.0 kDa PEGDA IPN formulation was able to support the initial stages
of MSC smooth muscle cell lineage progression in the presence of elongated cells.
Initial Assessment of IPN Thrombogenicity
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As an initial thrombogenicity assessment, collagen-PEGDA IPNs were exposed to porcine
whole blood under static conditions and the levels of platelet adhesion and clot formation
were assessed relative to collagen hydrogel positive controls. The degree of platelet adhesion
supported by the IPNs was ≈ 40% lower than that supported by the collagen controls (p =
0.001, Figure 10A) and clot formation was qualitatively reduced (Figure 10B). Thus, the
presence of PEGDA within the IPNs appeared to enhance their thromboresistance relative to
pure collagen hydrogels.

DISCUSSION
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The aim of the present work has been to develop an IPN which would retain the benefits of
collagen in terms of enabling robust cell elongation, but which would display enhanced
mechanical stiffness and strength, improved thromboresistance, and high resistance to
compaction. To allow for cell elongation within the IPN networks despite the presence of
PEGDA, a delay time was introduced between the formation of the cell-laden collagen
network and subsequent infiltration with PEGDA. This is in contrast to most IPNs, including
those previously formed from PEG and collagen [39], which are generally prepared by
mixing the two component polymers followed by their simultaneous crosslinking into
interwoven networks [25, 27, 28, 39]. In the present work, we have demonstrated that
collagen-PEGDA IPNs fabricated by this sequential polymerization process permit control
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over the degree of cell elongation, from rounded at a 0 h delay time to increasingly
elongated at a 6 h delay-time. MSC viability through the sequential polymerization process
was > 90%, irrespective of delay time. Furthermore, elongated MSCs within a ≈ 60 kPa
collagen-PEGDA IPN progressed through the initial stages of smooth muscle cell
differentiation when cultured in the presence of TGF-β3, a growth factor that can stimulate
either chondrogenesis or smooth muscle cell formation depending on the local cell
environment.
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In terms of mechanical properties, the observed improvement in rheological and tensile
moduli in the collagen-PEGDA IPNs relative to their single network counterparts is in
agreement with previous studies that used PEG [50] or poly (2-hydroxyethyl methacrylate)
(HEMA)-based IPN systems [59]. The synergistic increase in TS observed in the collagenPEGDA IPN relative to the additive TS of the component networks is also consistent with
existing IPN literature [27, 28]. Furthermore, the elasticity of the IPNs was greater than their
corresponding pure PEGDA counterparts, per loss tangent calculations. Given the
importance of biomaterial resistance to dilation in vascular graft applications, the ability to
modulate scaffold elasticity is advantageous in graft design.
Also, consistent with existing literature is the tunability of collagen-PEGDA IPN mechanical
properties in response to changes in PEGDA MW and collagen concentration. It is
anticipated that tailoring the PEGDA concentration in the infiltration solution would result
in a further broadening of achievable tensile and rheological properties [38, 60, 61],
although longer infiltration times may be needed for more concentrated PEGDA solutions to
reach equilibrium within the collagen hydrogel.
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Collagen-PEGDA IPNs containing elongated MSCs also exhibited a high degree of physical
stability, with construct dimensions being maintained over 14 days of culture with no
evidence of significant cell-mediated compaction. This is important for vascular graft
applications, where control over graft dimensions and stability is critical. Moreover, the
collagen-PEGDA IPNs displayed significantly reduced platelet adhesion and clot formation
relative to pure collagen hydrogels. Both the increased physical stability and increased
thromboresistance of the collagen-PEGDA IPNs relative to pure collagen hydrogels result
from the physical properties of PEGDA hydrogels. Specifically, the nanoscale crosslink
density and resistance to degradation characteristic of pure PEGDA networks limit cellmediated network compaction [57]. In addition, the non-fouling or passivating nature of
PEGDA is considered to underlie its thromboresistance [29, 30].
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This sequential polymerization/time-delay approach to creating hybrid natural-synthetic
IPNs containing elongated cells is not limited to collagen and PEGDA. For instance,
fibrinogen-based hydrogels could potentially be employed in place of collagen. Furthermore,
the fabrication of collagen-PEGDA IPNs with directionally aligned collagen fibers could be
achieved if the protein fibers are aligned prior to PEGDA infiltration and polymerization via
the application of mechanical strain or a magnetic field [3].
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CONCLUSIONS
In the present work, a collagen-PEGDA IPN has been developed which retains many of the
benefits of pure collagen hydrogels but which displays improved stiffness, strength, physical
stability, and blood compatibility. The introduction of a variable time delay between the
formation of the collagen hydrogel and the formation of the secondary PEGDA network
enables tight control over cell spreading, ensuring the robust cell elongation needed for
vascular graft applications despite the present of PEGDA. This ability to control the degree
of cell spreading combined with the broad tunability of the collagen-PEGDA IPN modulus
and strength also opens the potential use of these scaffolds in a range of other tissue
engineering applications.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Schematic representation of the sequential collagen-PEGDA IPN fabrication process.
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Figure 2.
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Change in IPN rheological properties and swelling as a function of PEGDA infiltration time.
(A) Shear storage modulus, (B) Shear loss modulus, (C) Mass swelling ratio. For each
formulation, n = 3–6 independent samples were measured. * significantly different from the
pure nominal 10 % w/v PEGDA hydrogel, p < 0.05; # significantly different from the pure 3
mg/mL collagen hydrogel, p < 0.05; + significantly different from the 15 min infiltration
time, p < 0.05; & significantly different from the 30 min infiltration time, p < 0.05.
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Figure 3.
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Influence of PEGDA molecular weight on IPN tensile properties. (A) Tensile modulus, (B)
Tensile strength. For each formulation, n = 3–5 independent samples were measured. *
significantly different from the 3.4 kDa PEGDA IPN, p < 0.05; # significantly different from
6.0 kDa PEGDA IPN, p < 0.05; + significantly different from the corresponding pure
PEGDA control, p < 0.05; & significantly different from the pure 3.4 kDa PEGDA hydrogel,
p < 0.05.
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Figure 4.

Representative confocal images of a transverse section through hydrogels immunostained
for collagen I: (A) a 3 mg/mL collagen hydrogel; (B) a nominal 10% w/v 6.0 kDa PEGDA
hydrogel; (C) a 6.0 kDa PEGDA IPN hydrogel at 60 min infiltration time. Scale bar = 50
μm.
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Figure 5.
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Microscopy-based assessment of IPN microstructure. (A) A representative SEM image of a
nominal 10% w/v 6.0 kDa PEGDA hydrogel control at 15,000X magnification, scale bar = 4
μm. The image inset shows the gel structure at 40,000X magnification; (B) A representative
SEM image of a 6.0 kDa PEGDA IPN, 60 min infiltration time at 15,000X magnification,
scale bar = 4 μm, arrow indicating a flat PEGDA structure surrounded by collagen fibrils.
The image inset shows the gel structure at 40,000X magnification.
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Figure 6.
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Cell shape descriptors (A) Circularity, (B) Roundness in 6.0 kDa PEGDA IPN.
Approximately 100 cells were evaluated for each time delay. * significantly different from
the 0 h time delay samples, p < 0.05.
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Figure 7.

Representative images of phalloidin-stained cells in collagen-PEGDA IPNs (3 mg/mL
collagen, 6.0 kDa PEGDA) as a function of the delay time between collagen network
formation and PEGDA infiltration. (A, D) 0 h delay time, (B, E) 4 h delay time, (C, F) 6 h
delay time. The cell cytoskeleton is stained with rhodamine phalloidin, and the cell nuclei
are stained with DAPI. The scale bars in (A, B, C) equal 20 μm and the scale bars in (D, E,
F) equal 100 μm.
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Figure 8.

Volume assessment of collagen-PEGDA IPNs (3 mg/mL collagen, 6.0 kDa PEGDA, 60 min
infusion time) containing elongated MSCs over 14 days of culture. (A) Average IPN
thickness at day 14 relative to day 0; (B) Representative images of day 0 and day 14 IPNs
relative to pure PEGDA and pure collagen control gels.
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Figure 9.

Gene expression of SMα-actin, SM22-α, CNN1, sox9 and collagen II by elongated MSCs
in a 6.0 kDa PEGDA IPN (60 min infusion time) following 14 days of culture relative to day
0. Gene expression was assessed relative to the housekeeping gene GAPDH and fold
differences were calculated using the ΔΔCt method. Four IPN discs were evaluated for each
time point. * significantly different from day zero, p < 0.05.
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Figure 10.

Initial thrombogenicity assessment. (A) 6.0 kDa PEGDA IPN (60 min infusion time) platelet
adhesion relative to collagen hydrogel positive controls, n = 4 samples per formulation. (B)
Representative images of clot formation on various hydrogel surfaces.
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6 kDa PEGDA IPN tensile modulus and tensile strength as a function of infiltration time.
Formulation

Tensile Modulus, E [kPa]

Tensile Strength, TS [kPa]

PEGDA 10 w/v% (nominal)

31.0 ± 4.2

46.1 ± 15.0

Collagen 3 mg/ml

ND

ND

15

37.2 ± 9.5

32.4 ± 15.3

30

62.8 ± 4.3a

77.4 ± 14.6b

45

78.6 ± 12.4a,b

120.7 ± 12.8a,b,c

60

70.8 ± 9.0a,b

107.8 ± 19.1a,b

Controls

Infiltration Time [min]

(ND) Not able to be determined with ring tension test;

a

significantly different from nominal 10% w/v 6 kDa PEGDA, p < 0.05;
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b

significantly different from 15 min infiltration time, p < 0.05;

c

significantly different from 30 min infiltration time, p < 0.05.
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Influence of PEGDA molecular weight on IPN shear storage, loss modulus and loss tangent.
Hydrogel

Shear Storage Modulus G′[kPa]

Shear Loss Modulus G″[kPa]

9.9 ± 1.9

2.0 ± 0.5

0.22 ± 0.06

16.9 ± 3.5c

2.0 ± 0.4c

0.12 ± 0.02c

4.9 ± 0.8

0.9 ± 0.2

0.19 ± 0.06

6.0 kDa PEGDA IPN

14.2 ± 3.7c

1.6 ± 0.4c

0.11 ± 0.01c

10.0 kDa PEGDA

3.5 ± 0.6d

0.6 ± 0.2d

0.19 ± 0.06

7.8 ± 0.3a,b,c

0.7 ± 0.3a,b

0.09 ± 0.04c

3.4 kDa PEGDA
3.4 kDa PEGDA IPN
6.0 kDa PEGDA

10.0 kDa PEGDA IPN

a

Loss tangent

significantly different from 3.4 kDa PEGDA IPN, p < 0.05;

b

significantly different from 6.0 kDa PEGDA IPN, p < 0.05;
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c

significantly different from corresponding PEGDA control, p < 0.05.
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Influence of collagen concentration on 6.0 kDa PEGDA IPN shear storage, loss modulus and loss tangent.
Collagen concentration [mg/mL]

a

Shear Storage Modulus G′ [kPa]

Shear Loss Modulus G″ [kPa]

Loss tangent

1.5

11.0 ± 4.6

1.2 ± 0.4

0.14 ± 0.02

3.0

14.2 ± 3.7

1.6 ± 0.4

0.12 ± 0.01

5.0

21.7 ± 4.1a,b

1.5 ± 0.3

0.07 ± 0.01a,b

significantly different from 1.5 mg/mL IPN, p < 0.05;

b

significantly different from 3.0 mg/mL IPN, p < 0.05.
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